Replies to post #176200 on Cytodyn Inc (CYDY)

[Learning53]

Theswordman,

My reference to "figuring out what to hell is going on" refers to the technical data surrounding all aspects of Leronlimab...and I mean ALL ASPECTS from MOA to Market and everything in between. I've been here over a year and a half - seriously reading, amassing data, wrapping my head around the different factors and I'm still challenged - just the vocabulary alone is mind-bending.

For that reason I've developed my own glossary to assist in comprehending and integrating the language. It's not something I wanted to do, but some of these terms appear with frquency and I need to understand them to comprehend the processes, how they relate to each other in a meaningful way, and what this portends. Here's a very brief sample from my personal glossary:


"Peptides
(from Greek language pept??, peptós "digested"; derived from p?sse??, péssein "to digest") are short chains of between two and fifty amino acids, linked by peptide bonds. Chains of fewer than ten or fifteen amino acids are called oligopeptides, and include dipeptides, tripeptides, and tetrapeptides.

Peripheral Arterial Tonometry (PAT) determines the peripheral arterial vascular tone using a plethysmographic method on the finger. The peripheral arterial tone is modulated by sympathetic activity, by peripheral blood pressure, and by the peripheral resistance of the vessels.

Perisynaptic schwann cells
Perisynaptic schwann cells are Neuroglia found at the Neuromuscular junction with known functions in synaptic transmission, synaptogenesis, and nerve regeneration.


Phagocytic Leukocyte
Phagocytic leukocytes role is to clean up the environment and digest the antigens found for presentation to the immune system. They are surveillance division of the immune system."


There is a lot of information to integrate and these 13d folks do not appear to have significant background (and the one that might have some has none OF HER OWN SKIN IN THE GAME).

To function effectively they'll need a data set that will (as I've already stated) NECESSITATE SIGNIFICANT time, energy, and challenge. Otherwise they will be just deadwood in the process.


A nightmare snapshot of the future:

Information comes in...what's that about...how does it affect CytoDyn/Leronlimab...what do you recommend...we don't have enough information...we're new...so here's what WE think should be done, except we really don't have a clue...maybe in a couple of years...maybe we should "break for a drink and think about this"..."Oooops time for that group picture [The new board] - look sharp everyone!"

Sort of like becoming the emergency room lead during the height of the pandemic when you know nothing about medicine other than how to apply a bandaid. Not very encouraging.

There probably are a few people out there that could replace or augment Nader. They are few and far between, but unfortunately the 13d folks are NOT the right ones.

Thanks for the offer 13d, but not interested. Sticking with Nader.